- BioRN Network
- Cluster Management
About 80 companies from the field of red biotechnology develop drugs, technology platforms and diagnostics at the Biotech Cluster Rhine-Neckar (BioRN). Globally acting healthcare companies as well as internationally renowned research institutes also play a significant part in this development.
With its focus on personalized medicine and cancer research the BioRN cluster occupies a leading position in Germany. In 2008 it was awarded the leading-edge cluster for “Cell based and molecular medicine in the Rhine-Neckar Metropolitan Region”
März 11, 2015
DKFZ: Deadly to cancer cells only: A molecular cause for selective effectiveness of parvovirus therapy discovered
März 06, 2015
DKFZ: A new tool for detecting and destroying norovirus
März 04, 2015
EMBL: Best of three worlds
Read our monthly BioRN Newsletter. It will keep you informed about what´s going on in the BioRN cluster.
» Find further future events here